A meta-analysis of nearly 25,000 patients undergoing radical prostatectomy supports adding presurgery MRI findings to ...

Meta-analysis shows several MRI-derived parameters were associated with outcomes ...

Add Yahoo as a preferred source to see more of our stories on Google. For men facing the return of prostate cancer, a new combination therapy may offer a much longer break before the disease comes ...

An experimental new treatment slows down the spread of metastatic prostate cancer, postponing the use of hormone treatment by at least 25 months, according to an international study headed by Nijmegen ...

A systematic review of 29,941 patients shows that preoperative MRI findings significantly improve risk stratification for men with prostate cancer undergoing radical prostatectomy.

Pre-treatment prostate MRI predicts recurrence and survival after surgery. Discover how imaging improves risk assessment.

Dr. Glenn Bauman, Scientist at LHSCRI and Radiation Oncologist at London Health Sciences Centre (LHSC), stands in front of the positron emission tomography (PET) scanner. LONDON, ON – A multicentre ...

UCLA researchers found that routine PSMA PET/CT scans could help doctors select treatment approaches for the best long-term outcomes in patients with recurring prostate cancer after surgical removal ...

A new treatment strategy tested by UCLA researchers could offer new hope for men whose prostate cancer has returned after initial treatment. This approach could also help delay the need for hormone ...

A common diabetes medication could help men with prostate cancer who develop hormone therapy-related metabolic syndrome ...